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1. Introduction
A consumer’s flavor experience is a highly dynamic 
process. Considering beverages as one of the ‘simplest’ 
scenarios—as no mastication is involved—the 
consumer’s olfactory sensation will start with the 
orthonasal aroma smelled from above the beverage, 
before it is introduced into the mouth. After a sip is 
taken, the retronasal aroma starts. Compounds are 
released from the beverage into the mouth cavity and 
transported by the airflow to the olfactory epithelium 
in the nose. During swallowing, volatile organic 
compounds (VOCs) are released as they pass by the 
throat, producing the so-called ‘swallow-breath’ 
that results in high intensities of some VOCs in the 
air exhaled just following swallowing. Some volatile 
compounds can remain in the breath airflow for 
seconds or minutes after swallowing, resulting in a 
prolonged persistence of the aroma in the oral cavity, 
and producing the sensation commonly known as 
‘after-smell’ or ‘after-odor’ [1, 2]. The food industry, 
as well as chefs, is increasingly coming to appreciate the 
importance of the quality, intensity and duration of 
such long-lasting sensations once a food or beverage 
has been swallowed, and considers them as an integral 
part of the food experience and quality. Particularly 
with beverages, where the liquid is often swallowed 
quickly, the after-odor may be the major element of 
the overall aroma perception. Hence, and in order to 
better understand the consumer’s experience when 
drinking a beverage, more systematic and detailed 
studies are needed to elucidate the processes governing 
the persistence of aroma compounds in breath air.
Besides their obvious relevance to food and aroma 
science and applications, these fundamental studies are 
also of great significance to health and medical applica-
tions. Indeed, diagnostic applications of breath VOCs 
will be affected equally by the persistence of VOCs 
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Abstract
The persistence of aroma compounds in breath after swallowing is an important attribute of the 
overall aroma experience during eating and drinking. It is mainly related to the coating of the oral 
tract with food residues and the interaction between volatile compounds and airway mucosa. We 
have studied the persistence of eight compounds (2,5-dimethylpyrazine, guaiacol, 4-methylguaiacol, 
phenylethylalcohol, ethylbutanoate, ethyloctanoate, isoamylacetate and 2-heptanone) both in-nose 
and in-mouth after administration of volatiles in gas phase (vapor) to five different panelists. By 
using volatiles in the gas phase, only the interaction with the mucosa is highlighted and the formation 
of a liquid coating in the oral and tracheal airway is avoided. The physicochemical properties of the 
compounds, mainly polarity and vapor pressure, determine the interactions of the volatiles with the 
airway mucosa. The use of different breathing protocols allowed the study of the differences between 
nasal and oral mucosa in volatile retention, with higher persistence of volatiles obtained in-mouth. 
Initial concentration also affected persistence, but only for compounds with high volatility and at low 
concentration.
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originating from the lungs and the alveoli. Hence a 
better understanding of the link between the physical 
properties of VOCs and their persistence in breath is of 
importance to both food aroma persistence and medi-
cal breath studies.
Aroma persistence in breath depends on a number 
of factors, where physiological effects, characteristics 
of the food matrix and physicochemical properties 
of the aroma compounds seem to play a key role [3]. 
Of these three, physiological factors are characteristic 
of each person and contribute to inter-individual dif-
ferences. These factors include naso-oropharyngeal 
volumes, saliva composition, mucus composition, soft-
palate opening and breath flow, among others. In the 
case of aqueous solutions swallowed immediately after 
consumption, aroma persistence was found to be inde-
pendent of the panelist, suggesting that physiological 
factors have little influence on those systems [3, 4].
The composition of the food matrix determines 
the partitioning of volatiles between the food product 
and the gas phase present in the oral cavity. Oral pro-
cesses (chewing, tongue movements, salivation) disrupt 
the food matrix, affecting the release of volatiles to the 
exhaled airflow and contributing to the overall sensation. 
After swallowing, a viscous layer containing residues of 
the food product diluted in saliva can form on the oral 
and oropharyngeal mucosa. This coating keeps releasing 
traces of odorants over time, thereby affecting persistence 
[5]. Aroma persistence will therefore depend both on the 
partition of volatiles between the coating film and exhaled 
air and the adhesion degree of the matrix material to the 
oral and nasopharyngeal mucosa. Camacho et al found 
that the fraction deposited on the anterior tongue surface 
increased linearly with the oil content of an oil and water 
emulsion, with more coating resulting in higher concen-
tration of lipophilic aroma compounds [6]. Some authors 
compared odorant persistence in breath after drinking 
an aqueous solution of the aroma compound (‘wet swal-
low’) or swallowing a gaseous aliquot of the compound 
(‘dry swallow’). They observed the persistence effect for 
isoamylacetate [7] and diacetyl [8] only in the case of the 
wet swallow, suggesting the existence of liquid residues 
on the oral tract and the weak interaction of those com-
pounds and the mucosa when they are in gas phase.
The physicochemical characteristics of the aroma 
compounds also determine their release from the food 
matrix and the interaction of those compounds with 
mucosa. In order to reduce matrix effects, several authors 
have studied aroma persistence using aqueous model 
solutions. Linforth and Taylor analyzed the persistence 
of 41 compounds in water and identified polarity, vola-
tility, length of the carbon chain and ether linkage as the 
main factors controlling aroma persistence [3]. Other 
studies also using water solutions pointed to volatility as 
the main contributor to aroma persistence [4, 7, 9].
The study of aroma persistence using volatile com-
pounds in gas phase eliminates all possible interactions 
between volatiles and the food matrix and also the 
possibility of food debris coating the walls of the oral 
tract after swallowing that could act as an aroma reser-
voir and release volatiles over time. Therefore, by using 
volatiles in gas phase, only interactions with mucosa 
or saliva would be revealed. These interactions are also 
important in breath research as inhaled compounds 
can be retained in the airway mucosa and released 
back to the breath flow, impacting the measurement of 
endogenous compounds [10].
In this study, the differences in persistence between 
the nasal and oral cavities are examined for several VOCs. 
For that purpose, aromatized air containing eight volatile 
compounds was administered to five panelists breathing 
according to four different breathing protocols and the 
exhaled breath was analyzed on-line by proton transfer 
reaction mass spectrometry (PTR-MS). The high sen-
sitivity of PTR-MS allowed the real-time analysis of 
volatiles in single breath exhalations [11, 12]. The breath-
by-breath data were then fitted to a power curve as done 
previously by Hodgson [9] and the decay rate was calcu-
lated. The volatiles studied were selected based on their 
differences with respect to physicochemical properties, 
mainly polarity, volatility and chemical class.
2. Materials and methods
2.1. Preparation of aromatized air
An aroma cocktail containing 2-heptanone 
(57 mg), guaiacol (349 mg), 4-methylguaiacol 
(594 mg), ethyloctanoate (202 mg), ethylbutanoate 
(210 mg), 2,5-dimethylpyrazine (112 mg), isoamylacetate 
(286 mg) and phenylethylalcohol (375 mg) was 
prepared. All compounds were mixed without solvent 
and a liquid aliquot of the cocktail (300 μl) was injected 
in a 40 l Tedlar bag filled with compressed air. The bag 
was left at 60 °C for 3 h to evaporate and equilibrate 
the volatile compounds. The same bag was used for 
all the experiments evaluating differences between 
compounds, panelists and breathing protocols. The 
concentration of all compounds in the bag was above 
their odor threshold and was high enough to ensure 
the monitoring of nose-space intensity changes over 
time. A different bag was prepared for evaluating 
differences in persistence as a function of compound 
concentration. Five panelists (three male and two 
female, aged 30–50) gave their consent to participate 
in the experiments.
2.2. Breathing protocols
Aromatized air (500 ml) was sampled from the Tedlar 
bag with a gas-tight syringe and injected in the nose 
or mouth of the panelist, depending on the breathing 
protocol. Four protocols were selected which defined on 
the one hand the mode by which the aroma cocktail was 
administrated to the panelist and, on the other hand, 
how the air was inhaled and then exhaled for subsequent 
on-line measurements by PTR-MS (figure 1). 
For all protocols, the volatiles were administered 
once during the first inhalation. Afterwards, the 
panelists continued breathing lab air for at least 5 min. 
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The breathing protocols were: M1, the volatiles were 
injected in and inhaled through the mouth, then air 
was exhaled through the mouth into the sampling 
device and fresh air was inhaled through the nose for 
each breath; M2: the volatiles were inhaled through the 
mouth and then, with a closed mouth, air was exhaled 
through the nose into the sampling device and air was 
inhaled through the nose; N1: the volatiles were inhaled 
through the nose and then air was exhaled through the 
nose and inhaled through the mouth; N2: the volatiles 
were inhaled through the nose and then, while the nose 
was closed with a clip, air was both exhaled and inhaled 
through the mouth. For all protocols, the breath rhythm 
was defined as 3 s inhalation and 3 s exhalation, and was 
paced with a metronome during the experiments. All 
five panelists performed each breathing protocol in 
triplicate.
2.3. Dose–response
Different concentrations were prepared by dilution 
of the aromatized air, bringing the compound 
concentration closer to real food situations. 
Dilution was made directly into the syringe prior 
to administration: different volumes (50, 100, 200, 
300, 400, 500 ml) were taken from the bag containing 
aromatized air and then the syringe was filled back up to 
500 ml with non-aromatized lab air. Blanks containing 
lab air were analyzed to ensure that it was free of VOCs 
that could interfere with the measurements. Two 
replicates of each concentration were administrated to 
two different panelists.
2.4. Exhaled air sampling
Volatile concentration in the exhaled air was monitored 
via proton transfer reaction quadrupole mass 
spectrometry (PTR-QMS) (Ionicon GmbH, Austria). 
Two inlet systems were used, depending on whether 
the air was exhaled through the nose or through the 
mouth. For nose sampling, a commercial nosespace 
air sampling extension (Ionicon GmbH, Austria) was 
used. For mouth sampling, a custom-built setup was 
used. The setup contained a removable mouth tip that 
was changed for each panelist, mounted on a one-way 
respiratory valve (Hans Rudolph Inc., USA) equipped 
with a membrane to prevent saliva from passing through 
the system. The valve was connected by a T-piece to the 
PTR-QMS inlet sampling 40 ml min−1 and the other 
side was left open to expel the excess of the exhaled 
air. The whole system was heated to 90 °C to prevent 
a condensation of the volatiles. To check for volatile 
retention on the sampling setups, compressed air was 
connected to the setup immediately after exhalation of 
the volatile mixture. It was observed that all mass signals 
instantaneously returned to background levels.
2.5. PTR-MS conditions
A commercial PTR-MS with a quadrupole detector was 
used. The PTR conditions were as follows: 160 °C inlet 
temperature, 80 °C drift tube temperature, 2.2 mbar 
drift tube pressure, 495 V drift voltage, yielding an 
E/N value of 120 Td. The same dwell time (50 ms) was 
used for all the m/z measured: 71 (isoamylacetate), 105 
(phenylethylalcohol), 109 (2,5-dimethylpyrazine), 115 
(2-heptanone), 117 (ethylbutanoate), 125 (guaiacol), 
139 (4-methylguaiacol), 173 (ethyloctanoate). 
The headspace of each compound was analyzed to 
determine its fragmentation under the selected PTR-
MS conditions and the data were corrected accordingly. 
No overlap was observed between the selected m/z, with 
the exception of an ethyloctanoate fragment of m/z 109 
(<1%) which overlapped with 2,5-dimethylpyrazine. 
The data obtained for 2,5-dimethylpyrazine were 
corrected for the ethyloctanoate contribution.
2.6. Data processing
Exhalations were identified by the increase of the 
acetone signal (m/z 59). Intensity was measured during 
the 3 s of each exhalation, resulting in five data points 
for each compound (550 ms scan rate). Since the signal 
intensity was essentially constant over the 3 s exhalation 
Figure 1. Representation of the aromatized gas administration (left) and scheme of the four different breathing protocols used in 
the study (right). After the administration of aromatized air in the first inhalation, the panelist freely breathed room air.
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window, the intensity for each compound was given 
as the average intensity over the five data points 
measured for each exhalation. Before administration 
of aromatized air, five exhalations were recorded each 
time to determine the background levels. The first 
exhalation was discarded from data analysis; starting 
with the second exhalation, the background corrected 
intensities of the exhalation signals were fitted to a 
power curve I  =  at−b where I was the intensity at 
time t. The two parameters obtained from the fitting 
represented the intensity at the beginning (a) and the 
decay rate (b) of the volatile compound.
Analysis of variance (ANOVA) was performed to 
assess the effect that compounds, panelists, breathing 
protocols or concentration had on the power curve 
parameters. Significant differences were obtained 
using Tukey’s honest significant difference post hoc 
test (p  <  0.01). All analyses and the creation of graphs 
were performed with packages and scripts developed 
in R [13].
3. Results
The concentration of volatiles in the exhaled breath 
was monitored on-line by PTR-MS for 5 min following 
the one-time administration of aromatized air. Two 
minutes after inhalation of the aroma mixture, volatile 
levels in the exhaled air were close to background levels. 
Therefore, only the first 2 min were used for further 
calculations. For each breath, the concentration in 
the exhaled air was averaged and plotted against the 
time at the end of the exhalation. The first exhalation 
contained aromatized air that remained in the dead 
space of the airway (where no gas exchange takes place), 
resulting in a sharp peak of high intensity followed 
by a shoulder (figure 2(A)). This first exhalation was 
therefore discarded and only the following ones, 
containing those volatiles that had been retained 
on the respiratory tract and then released breath by 
breath, were considered [9]. As previously done by 
Hodgson et al using aqueous solutions, we described 
the long-time persistence of volatiles by fitting the 
concentrations of the second breath onwards to a 
power curve I  =  at−b (figure 2(B)), where the factor b 
represents the decay rate.
3.1. Differences in persistence between compounds
Differences in persistence were observed for the 
eight compounds studied (2,5-dimethylpyrazine, 
ethylbutanoate, ethyloctanoate, guaiacol, 2-heptanone, 
isoamylacetate, 4-methylguaiacol, phenylethylalcohol). 
Figure 3 shows the boxplots of the calculated decay 
rates for each compound, including the results from all 
experiments carried out (5 panelists  ×  4 protocols  ×  3 
Figure 2. Ten breath-by-breath intensity profiles for 2,5-dimethylpyrazine to show the raw data (A). Plot of 25 intensity averaged 
exhalations (150 s) fitted to a power curve (B) and with logarithmic axes (C).
Figure 3. Boxplots for the decay rate (b) of the eight compounds considering all panelists and breathing protocols with letters 
marking significant differences in decay rate among the compounds (Tukey’s test, p  <  0.01). Physicochemical data of the 
compounds were obtained via ChemSpider, an open-access online chemical database hosted by the Royal Society of Chemistry 
(www.chemspider.com).
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replicates  =  60 measurements for each compound). 
The calculated decay rates (b) presented statistically 
significant differences among the compounds even 
when all measurements were considered, indicating 
that compound physicochemical properties had a 
higher impact on persistence than the panelist or the 
breathing protocol used (figure 3). Two main groups 
of compounds can be differentiated according to their 
decay rate: those with fast decreasing intensities, which 
correspond to compounds with lower water solubility 
and high volatility (2-heptanone, isoamylacetate 
and ethylbutanoate), and those presenting a much 
slower decay, which are highly soluble in water 
(2,5-dimethylpyrazine, guaiacol, 4-methylguaiacol and 
phenylethylalcohol).
3.2. Differences in persistence between panelists
Inter-individual differences were observed in the 
decay rate (b) for most of the compounds and they 
were dependent on the breathing protocol used. To 
determine those differences among panelists, an 
ANOVA test was performed for each of the compounds 
and protocols used. A complete list of the decay rates 
with statistically significant differences is shown in 
table 1. In this section, only the general trends within 
each of the breathing protocols are discussed.
Breathing protocol M1 resulted in significant dif-
ferences between panelists for all compounds except 
for isoamylacetate. For the other compounds, the 
highest decay rate was found for P3 and the lowest 
for P1 and P2, which showed higher persistence. For 
protocol M2, no significant differences were found 
for guaiacol, 4-methylguaiacol, phenylethylalcohol 
and ethylbutanoate. In the case of ethylbutanoate, 
one of the replicates of P5 was most probably an out-
lier as it yielded an extremely high decay rate, which 
affected the ANOVA and resulted in no differences 
between the five panelists. After removal of the out-
lier, a significantly higher decay rate was observed for 
panelist 4 with no significant differences between the 
other four panelists (table 1). Regarding the rest of 
the compounds, P1 and P2 had generally higher per-
sistence. Protocol N1 also showed no differences for 
guaiacol, 4-methylguaiacol and phenylethylalcohol. 
P1 again showed lower values of decay for the other 
compounds, but this time P2 had the fastest decay. 
The last protocol revealed no differences for ethyloc-
tanoate, 2-heptanone and isoamylacetate. P2 and P3 
had the slowest decay for guaiacol, 4-methylguaiacol, 
2,5-dimethylpyrazine and isoamylacetate.
It is interesting to note that for M2 and N1, the two 
protocols that involved breathing through the nose after 
volatile inhalation, no differences were found between 
panelists for those compounds with lower values of Kow 
and Kaw (with the exception of 2,5-dimethylpyrazine). 
In the case of N2, where breathing was done by the 
mouth, the picture is the opposite, with no differences 
found for compounds with high values of Kow and Kaw 
(with the exception of ethyloctanoate).
3.3. Differences between protocols
Differences both in measured intensity and decay 
rate were found between the compounds. Figure 4 
shows the decay curves of all the compounds and 
protocols for one of the panelists (P1). Regarding 
intensity, M1 presents the highest intensity for all 
the compounds independently of the panelist, but 
the rest of the protocols did not show statistically 
significant differences. This trend can be observed by 
comparing the intensity at time 1 s, calculated from the 
fitted data (table 1—parameter a). By comparing the 
intensity of the volatiles measured in the second breath, 
interesting trends could be observed. Compounds 
with low values of Kow and Kaw (2,5-dimetylpyrazine, 
guaiacol, 4-methylguaiacol and phenylethylalcohol) 
presented intensities for M2 in the range of 5%–17% 
of those obtained for the M1 protocol. For the rest 
of the compounds (heptanone, ethylbutanoate, 
ethyloctanoate and isoamylacetate), the intensities 
for the M2 protocol were between 10%–70% of M1. 
Similarly, for protocols N1 and N2, the highly water-
soluble group of compounds showed in N2 intensities 
that were lower than or in the same range as those of 
N1 (20%–100% of the N1 intensity) while the group 
containing fewer polar and highly volatile compounds 
generally presented higher intensities for N2 than for 
N1 (80%–410% of the N1 intensity).
Differences in persistence between the breathing 
protocols are less pronounced. Decay rates are similar 
for all the protocols with the only exception of N1 that 
shows higher decay for some compounds (guaiacol, 
methylguaiacol and phenylethylalcohol), indicating 
lower persistence on this breathing protocol. Table 1 
shows the decay rate for all breathing protocols. Again, 
we can cluster the compounds in two main groups 
with similar behavior: compounds with high Kow and 
Kaw and low vapor pressure presented differences in 
fewer than two panelists and compounds with low Kow 
and Kaw and high vapor pressure showed differences 
between protocols for at least three panelists. In order to 
get a better understanding of the effect of the breathing 
protocol on persistence, we considered all the panelists 
together for each of the protocols. No significant differ-
ences among the breathing protocols were observed for 
the decay rates of ethyloctanoate, ethylbutanoate and 
2-heptanone. In contrast, isoamylacetate and meth-
ylguaiacol presented significant differences, with the 
proto cols involving mouth breathing (M1 and N2) 
being the ones with lower decay rates. For phenylethyla-
lcohol and guaiacol, the only significant difference was 
found for the N1 protocol in which the decay rate was 
higher. 2,5-Dimethylpyrazine had a significantly higher 
decay rate on the M1 and N1 protocols.
3.4. Dose–response
To assess the influence of volatile concentration on 
aroma persistence, different volumes of aromatized 
air were sampled with the gas-tight syringe and diluted 
with clean air prior to administration to two panelists.
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Table 2 shows the differences in power fit para-
meters for all compounds and breathing protocols. 
 Figure 5 shows the decay curves for 2,5-dimethyl-
pyrazine for the four protocols and two panelists. Dif-
ferences in measured intensity were observed for the 
different concentrations administered, but the decay 
rate seemed to be affected only for the lowest concen-
trations considered. This is discussed further in the 
next section.
The curve fitting parameters for all compounds and 
protocols are shown in table 2. The parameter a, which 
was the calculated intensity at the beginning, increased 
with increasing concentration (volume of aromatized 
air), although differences were not always statistically 
significant. Parameter a represented the estimated con-
centration at time 1 s using the power fit and therefore 
was expected to be proportional to the concentration 
administered. The lack of significance observed may 
have resulted from inter-individual differences between 
the two panelists, as the high values for the standard 
deviation seemed to indicate.
This effect was particularly high for protocol M2, 
resulting in no significant differences for any of the 
compounds. To eliminate inter-individual differences 
and to check the effect of administering different con-
centrations of aroma compounds in the exhaled breath, 
we performed a linear regression on the measured 
intensity in the second exhalation for each of the com-
pounds, protocols and panelists. Values for the regres-
sion coefficient (r2) are shown in table 3. Although the 
data did not always perfectly fit a linear regression, a 
correlation between the concentration delivered to 
the panelist and the intensity of the compounds in the 
exhaled breath was clear.
The effect of concentration on persistence was less 
pronounced. Only the decay rate of one compound 
(2,5-dimethylpyrazine) was significantly affected by the 
concentration independently of the breathing proto-
col (table 2). Higher concentrations resulted in faster 
decay rates for this compound with the decay rate at the 
highest concentration doubling that at the lowest one. 
Other compounds presented similar behavior, but only 
in certain protocols with significant differences in per-
sistence between low and high concentrations for eth-
ylbutanoate (protocol M1), ethyloctanoate (protocols 
M1 and N2) and 2-heptanone (protocols M1 and N1).
4. Discussion
4.1. Aroma persistence mainly depends on 
the physicochemical properties of the volatile 
compounds when delivered in the gas phase
The impact of compound physicochemical properties 
on the decay rate, and therefore on the persistence 
of the compounds in breath, when in the gas phase, 
was proven to be higher than the differences between 
different panelists or breathing protocols. A trend 
was observed between compound persistence and 
hydrophilicity (Kaw, Kow) and volatility (vapor 
pressure). The less hydrophilic but highly volatile 
compounds (i.e. isoamylacetate) showed a faster 
decay than the highly water-soluble and less volatile 
ones (i.e. 2,5-dimethylpyrazine). This relationship 
is to be expected as it has already been reported in 
Figure 4. Decay curves for panelist P1. Lines represent the fit of three replicates and color ribbons the 95% confidence level of the fit.
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aqueous solutions [9, 14], in theoretical models of 
volatile transport in the respiratory tract [15, 16] and 
in studies on the impact of inhaled compounds on 
their concentrations in exhaled breath [10]. In studies 
with solutions, persistence depends not only on the 
absorption and depletion of volatiles from the mucus, 
but also on the release of volatiles from beverage 
residues coating the throat [7]. In fact, Hodgson 
et al found that swallowing an aqueous solution of 
isoamylacetate (wet swallow) resulted in the persistence 
of the aroma compound in subsequent exhalations, 
whereas a swallow of the same compound in gas phase 
(dry swallow) did not show any evidence of persistence. 
The same results were obtained for diacetyl in a different 
study [8]. Therefore, they attributed most of the 
persistence effect to volatile release from a liquid film 
remaining within the oral tract and containing residues 
of the beverage product. In our case, isoamylacetate 
inhaled in gas phase did show evidence of persistence, 
although its decay rate was the fastest of all compounds 
analyzed. This discrepancy in results might come 
from the difference in volatile administration as in 
Hodgson’s work the gas phase was swallowed: the 
volatiles passed from the pharynx to the esophagus and 
could not go back to the air-tract during breathing. In 
ours the gas phase was inhaled: the volatiles passed from 
the pharynx to the larynx and trachea, where they could 
be absorbed on the nasal mucosa and were released 
again during respiration. Furthermore, swallowing 
will remove an important fraction of saliva from the 
oral cavity, together with dissolved volatile compounds.
The importance of the coating layer in volatile 
persistence, and therefore for after-smell sensations, is 
also indicated by the differences in persistence between 
our work with aromatized air and those with aqueous 
solutions found in the literature. Linforth and Taylor 
measured the volatile persistence of dimethylpyrazine, 
guaiacol, isoamylacetate and ethylbutanoate expressed 
as the ratio between the first and second exhalations 
after swallowing an aqueous solution [3]. Comparing 
Linforth’s ratios with those obtained using the closest 
breathing protocol to real consumption (M2—where 
the volatiles were injected into the mouth and then 
breathed in and out through the nose), we observed 
that persistence was 15%–35% higher on aqueous 
solutions for all compounds except ethylbutanoate. For 
this compound, persistence values were comparable to 
those of Linforth and Taylor [3] and Wright et al [17], but 
Figure 5. Decay curves for 2,5-dimethylpyrazine at six different concentration levels for the four breathing protocols studied. Lines 
represent the fit of four measurements (2 replicates  ×  2 panelists) and color ribbons the 95% confidence level of the fit.
Table 3. Linear fit regression coefficients. A linear fit was performed for each panelist and compound using the intensity of the compound 
exhaled on the second breath (in duplicate) as a function of the concentration administered.
Regression  
coefficient (r2)
2,5- 
Dimethylpyrazine Ethylbutanoate Ethyloctanoate Guaiacol
2- 
Heptanone Isoamylacetate
4- 
Methylguaiacol Phenylethylalcohol
Panelist 1
M1 0.9400 0.8222 0.9087 0.8616 0.9672 0.9148 0.7770 0.7467
M2 0.6268 0.4582 0.8616 0.5884 0.9375 0.9293 0.7160 0.6557
N1 0.9245 0.7682 0.9672 0.8440 0.8892 0.9455 0.3103 0.8738
N2 0.9134 0.8982 0.9148 0.8254 0.9413 0.8611 0.7765 0.8417
Panelist 2
M1 0.9463 0.7726 0.9004 0.9126 0.9304 0.8715 0.8841 0.8738
M2 0.9226 0.3965 0.9126 0.8510 0.9605 0.5451 0.8125 0.4518
N1 0.7844 0.8187 0.9304 0.7356 0.9542 0.9747 0.6808 0.6057
N2 0.6709 0.6669 0.8715 0.7249 0.7366 0.6658 0.6678 0.2053
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much lower than the persistence reported by Buffo also 
using an aqueous solution [4]. Similar observations 
can be made by comparing the decay rates measured 
in this work with those reported by Hodgson et al [7, 
9] as depicted in figure 6. They measured decay rates 
for 2,5-dimethylpyrazine (0.53 in-nose and 0.55 in-
mouth) and ethylbutanoate (1.60 in-mouth), while the 
decay rates obtained in our study after inhaling aroma-
tized air by the mouth were 0.77 (M2, in-nose) and 0.98 
(M1, in-mouth) for 2,5-dimethylpyrazine and 2.37 
(M1, in-mouth) for ethylbutanoate. The higher persis-
tence (lower decay rate) of the compounds in aqueous 
solutions could again be attributed to residues of the 
aqueous solution that remained in the oral tract and 
acted as aroma reservoirs.
4.2. Volatile persistence depends on the breathing 
protocol
The effect of the breathing protocol on both intensity 
and persistence was compound-dependent. The highest 
intensity for all compounds was measured during the 
M1 breathing protocol. The M1 and M2 protocols 
shared the way the aromatized air was administered to 
the panelist: the volatiles were injected into the mouth 
and inhaled. Inhaled volatiles could be absorbed at any 
point of the airway from the oral cavity to the alveoli, 
where they could be drawn into the blood stream. 
Before the first exhalation, the dead space of the airway 
was filled with a fraction of the aromatized air supplied. 
From this point onward, both protocols differed. On the 
M1 protocol, air was exhaled through the mouth. On the 
first exhalation, the volume of air in the dead space was 
flushed out by air from the lungs and expelled through 
the mouth. After the first exhalation, air was inhaled 
through the nose and exhaled through the mouth in the 
whole duration of the experiment. During inhalation, 
only compounds absorbed on the respiratory tract, 
from the pharynx to the lungs, could be released into the 
air flow and incorporated into the blood flow to some 
extent. During exhalation, it cannot be excluded that a 
fraction of the compounds formerly transferred to the 
blood was transferred back to the exhaled breath flow, 
together with a portion of the compounds absorbed in 
the whole respiratory tract, including the mouth cavity. 
Therefore, the fraction absorbed in the mouth cavity 
would only be depleted during exhalations and not 
during inhalations. On breathing protocol M2, the first 
exhalation was done through the nose. Aromatized air 
in the dead space was also flushed out by the air coming 
from the lungs, but in this case, a fraction of the volatiles 
were expected to be retained by the nasal mucosa which 
was free of the volatile mix before the first exhalation. 
Subsequent breathings were performed only through 
the nose. Nose breathing necessitates closing of the 
velum with the back of the tongue, to prevent volatiles in 
the mouth cavity from passing to the airflow (Buettner 
et al [18]). Therefore, during exhalation, volatiles 
measured in the breath corresponded to the fraction 
released from the respiratory tract, including the nasal 
cavity, but not the mouth cavity. That would result in 
M1 being higher than M2 as it included volatiles from 
the mouth cavity and did not illustrate loss through the 
nasal mucosa. In fact, M1 resulted in the highest intensity 
of all the breathing protocols tested, but the ratio M2/
M1 depended on the compound. The lower M2/M1 
ratio observed for the higher-polarity compounds 
indicates that those compounds were highly retained 
in the oral cavity and released in high concentrations 
to the exhaled breath in the M1 protocol, and that a big 
fraction were retained during nose exhalation in M2, 
due to absorption into the nasal mucosa. The less polar 
compounds presented lower M2/M1 ratios, indicating 
less retention of these compounds in the mucosa. Van 
Ruth and co-workers measured the concentration at 
the nostrils and compared it with the concentration 
at the nasopharynx for diacetyl, ethylbutanoate and 
ethylhexanoate. In all cases, only 60%–70% of the 
concentration in the nasopharynx reached the nostrils 
[19], and this retention by nasal mucosa is expected to be 
higher for more polar and less volatile compounds [20].
A similar situation was expected with breath-
ing protocols N1 and N2, with N1 including volatiles 
retained in the nose and respiratory tract and N2 con-
taining only volatiles absorbed in the respiratory tract 
during inhalation or in the mouth cavity during the first 
exhalation. Interestingly, the intensity on the N1 proto-
col was higher than that of N2 for the polar compounds, 
but the N2 breathing protocol resulted in higher con-
centrations than N1 for the less polar ones. This find-
ing implies that the retention of less polar and highly 
volatile compounds in the nose is lower than that in 
the mouth cavity. Higher retention in the mouth might 
be explained by the presence of saliva. Saliva composi-
tion can affect the partition coefficient of the volatiles, 
with the salting out of hydrophilic compounds and the 
Figure 6. Comparison between the measured decay rates for 
2,5-dimethylpyrazine and ethylbutanoate in gas phase and 
those reported in literature for aqueous solutions.
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non-covalent binding of hydrophobic ones by proteins 
[21, 22].
Differences in decay rate were much lower. Despite 
their different intensities among the protocols, three 
compounds presented no significant differences 
in decay rate (ethylbutanoate, ethyloctanoate and 
2-heptanone). This result implies that although 
the concentration retained in the mouth mucosa 
was higher than that in the nose, the mechanisms of 
absorption and release of the compounds must be 
similar, therefore not affecting the decay rate. For the 
rest of the compounds, N1 always exhibited the fast-
est decay. The lower persistence might be an effect 
of lower absorption in nasal mucosa or loss of vola-
tiles by incorporation into the blood that will pref-
erably affect the most polar compounds [20, 23]. 
Some compounds presented decay rates that were 
not significantly different from those of N1 in other 
breathing protocols: isoamylacetate and methyl-
furan on the M2 protocol, the other protocol that 
involved nose exhalation; and 2,5-dimethylpyrazine 
for M1. As we have presented in section 3.4 and will 
discuss in the next section, 2,5-dimethylpyrazine was 
the compound that exhibited higher differences in 
persistence with concentration. In both the M1 and 
N1 protocols, the 2,5-dimethylpyrazine concentra-
tion was significantly higher than in the other two 
protocols and that might be the reason for the higher 
decay rate obtained for this compound.
4.3. Concentration of volatiles has low impact on 
persistence
Administration of  higher concentration of 
volatiles resulted in higher intensities in exhaled 
breath for all compounds and protocols, but only 
2,5-dimethylpyrazine showed significant differences 
in decay rate, independently of the breathing protocol 
used. A lower decay rate for menthone with low 
concentrations has been reported after swallowing 
of aqueous solutions [7], but no differences have also 
been reported for other compounds [17]. In this study, 
this change of behavior with low concentrations has 
also been observed for ethylbutanoate (protocol M1), 
ethyloctanoate (protocols M1 and N2) and 2-heptanone 
(protocols M1 and N1), the most volatile compounds—
and only for the lowest concentration applied.
5. Conclusions
In this study we have analyzed for the first time the 
aroma persistence of volatile aroma compounds 
administered in the gas phase. With the approach taken 
here, we eliminated the interactions of the volatile 
compounds with the food matrix and the prolonged 
release from food residues that remain in the oral 
tract after swallowing. Therefore, persistence was only 
dependent on the interaction between the volatile 
compounds and mucosa. Three main learnings can be 
drawn from this systematic study: (i) The persistence 
of aroma compounds in the oral and nasal cavities is 
mainly dependent on the physicochemical properties 
of the volatile compounds. The compounds with high 
volatility and lower water solubility were the least 
persistent in the breath. (ii) The impact of a compound’s 
physicochemical properties on its persistence in breath 
was higher than the differences between different 
panelists and breathing protocols. Still, the persistence 
of volatiles was shown to vary among breathing 
protocols. By using different breathing protocols, 
differences in aroma retention and subsequent release 
between the nasal and oral cavities were highlighted, 
with higher concentrations found in the oral cavity 
for all the compounds and longer persistence in the 
mouth for the most water-soluble compounds. (iii) The 
concentration of the aroma compound slightly affected 
persistence, but only for the most volatile compounds 
and in the lowest concentration range administered to 
the panelist. Otherwise, persistence showed barely any 
dependence on concentration.
This study has obvious implications to aroma per-
sistence in food applications. But it is equally relevant 
in the health and medical context. Indeed, VOCs will 
be equally affected, irrespective of whether they origi-
nate from foods in the mouth or are transported by air 
coming from the lungs and the alveoli. The retention of 
compounds in the airway has several implications. The 
most obvious is that the amount of volatiles measured 
in exhaled air would be lower than that in the lungs, as 
some compounds will be retained by the mucosa. Also, 
the release of those volatiles back into the breath flow 
means that they will be detected over time even in the 
absence of metabolic reactions—production or deg-
radation of the compound. Therefore, the persistence 
of compounds in breath due to interactions with the 
mucosa needs to be taken into account when studying 
dynamic processes by breath analysis (i.e. metabolic 
rate, pharmacokin etics). A better understanding of 
the link between the compound properties of VOCs 
and their persistence in the exhaled air will therefore 
assist as well in the application and interpretation of 
health-related and medically-related breath analysis.
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